FDA Authorizes Combination Test for Flu and CCP Virus

A nurse holds a completed test with patient samples at a drive-through testing site for the new CCP virus in Washington state in a March 9, 2020, file photograph. Lindsey Wasson/Reuters

The Food and Drug Administration (FDA) issued an emergency use authorization (EUA) of a diagnostic test for the detection of viruses that cause flu and CCP virus also called COVID-19 on July 2, ahead of the upcoming flu season.

“With the authorization of these tests, the FDA is helping address concerns in anticipation of this upcoming flu season during the COVID-19 pandemic, which might be especially worrying for some Americans. This is another example of the FDA working with test developers to bring important diagnostics to Americans,” said FDA Commissioner Stephen M. Hahn, in a statement.